Molecular and Clinical Advances in Anticancer Drug Resistance edited by Robert F. Ozols.

The importance of drug resistance in cancer chemotherapy cannot be over­ stated. The 500,000 patients who die every year from cancer in the United States have, in most cases, been treated with chemotherapy. Many of these patients responded initially to chemotherapy, but death resulted from the devel...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Ozols, Robert F. (Editor)
Format: eBook
Language:English
Published: New York, NY : Springer US : Imprint: Springer, 1991.
Edition:1st ed. 1991.
Series:Cancer Treatment and Research, 57
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.

MARC

LEADER 00000nam a22000005i 4500
001 b3241031
003 MWH
005 20191028161252.0
007 cr nn 008mamaa
008 121227s1991 xxu| s |||| 0|eng d
020 |a 9781461538721 
024 7 |a 10.1007/978-1-4615-3872-1  |2 doi 
035 |a (DE-He213)978-1-4615-3872-1 
050 4 |a E-Book 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
245 1 0 |a Molecular and Clinical Advances in Anticancer Drug Resistance  |h [electronic resource] /  |c edited by Robert F. Ozols. 
250 |a 1st ed. 1991. 
264 1 |a New York, NY :  |b Springer US :  |b Imprint: Springer,  |c 1991. 
300 |a XII, 308 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Cancer Treatment and Research,  |x 0927-3042 ;  |v 57 
490 1 |a Springer eBook Collection 
505 0 |a 1. New Mechanisms of Gene Amplification in Drug Resistance (The Episome Model) -- 2. DNA-Damage Inducible Genes -- 3. Molecular Biology of P-Glycoprotein -- 4. Resistance to Inhibitors of DNA Topoisomerases -- 5. Expression of the MDR1 Gene in Human Cancers -- 6. Immunoblot Detection of P-Glycoprotein in Human Tumors and Cell Lines -- 7. Modulators of P-Glycoprotein-Associated Multidrug Resistance -- 8. Clinical Implications of Multidrug Resistance to Chemotherapy -- 9. The Role of P-Glycoprotein in Drug-Resistant Hematologic Malignancies -- 10. DNA Repair in Drug Resistance: Studies on the Repair Process at the Level of the Gene -- 11. Mechanisms of Resistance to Cisplatin -- 12. The Role of Metallothioneins in Anticancer Drug Resistance -- 13. Modulation of Antitumor Alkylating Agents (AA). 
520 |a The importance of drug resistance in cancer chemotherapy cannot be over­ stated. The 500,000 patients who die every year from cancer in the United States have, in most cases, been treated with chemotherapy. Many of these patients responded initially to chemotherapy, but death resulted from the development of drug-resistant tumors. In the first volume in the series. Drug Resistance in Chemotherapy the results of comprehensive laboratory studies aimed at understanding the mechanisms for resistance to individual agents and to the development of broad cross-resistance were described. In the past 2 years there has been substantial progress in understanding the molecular biology associated with these mechanisms of drug resistance. For the first time we are starting to understand which mechanisms are playing an im­ portant role in human tumors, and even more importantly, clinical trials have recently been initiated in an effort to reverse specific forms of drug resistance. The purpose of this volume is to describe the new advances, both at the molecular level and in the clinic regarding mechanisms of drug resistance and potential ways this resistance can be circumvented. This volume is focused upon mechanisms of resistance associated with two major classes of anticancer drugs: alkylating agents (including cisplatin) and the natural products (e. g. , adriamycin and vinblastine). The first section of the book describes new insights into the genetic mechanisms associated with drug resistance. 
590 |a Loaded electronically. 
590 |a Electronic access restricted to members of the Holy Cross Community. 
650 0 |a Oncology  . 
650 0 |a Pharmacology. 
690 |a Electronic resources (E-books) 
700 1 |a Ozols, Robert F.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
830 0 |a Cancer Treatment and Research,  |x 0927-3042 ;  |v 57 
830 0 |a Springer eBook Collection. 
856 4 0 |u https://holycross.idm.oclc.org/login?auth=cas&url=https://doi.org/10.1007/978-1-4615-3872-1  |3 Click to view e-book  |t 0 
907 |a .b32410311  |b 04-18-22  |c 02-26-20 
998 |a he  |b 02-26-20  |c m  |d @   |e -  |f eng  |g xxu  |h 0  |i 1 
912 |a ZDB-2-SME 
912 |a ZDB-2-BAE 
950 |a Medicine (Springer-11650) 
902 |a springer purchased ebooks 
903 |a SEB-COLL 
945 |f  - -   |g 1  |h 0  |j  - -   |k  - -   |l he   |o -  |p $0.00  |q -  |r -  |s b   |t 38  |u 0  |v 0  |w 0  |x 0  |y .i21541966  |z 02-26-20 
999 f f |i 6d11f029-0240-53a8-ae3e-6202c0a7e23e  |s 36de9dc0-17d3-5c65-8670-3786ebf15649  |t 0 
952 f f |p Online  |a College of the Holy Cross  |b Main Campus  |c E-Resources  |d Online  |t 0  |e E-Book  |h Library of Congress classification  |i Elec File